Correlation Between ProShares Decline and Virtus LifeSci

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ProShares Decline and Virtus LifeSci at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProShares Decline and Virtus LifeSci into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ProShares Decline of and Virtus LifeSci Biotech, you can compare the effects of market volatilities on ProShares Decline and Virtus LifeSci and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProShares Decline with a short position of Virtus LifeSci. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProShares Decline and Virtus LifeSci.

Diversification Opportunities for ProShares Decline and Virtus LifeSci

-0.87
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between ProShares and Virtus is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding ProShares Decline of and Virtus LifeSci Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virtus LifeSci Biotech and ProShares Decline is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProShares Decline of are associated (or correlated) with Virtus LifeSci. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virtus LifeSci Biotech has no effect on the direction of ProShares Decline i.e., ProShares Decline and Virtus LifeSci go up and down completely randomly.

Pair Corralation between ProShares Decline and Virtus LifeSci

Given the investment horizon of 90 days ProShares Decline is expected to generate 2.1 times less return on investment than Virtus LifeSci. But when comparing it to its historical volatility, ProShares Decline of is 1.7 times less risky than Virtus LifeSci. It trades about 0.02 of its potential returns per unit of risk. Virtus LifeSci Biotech is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  2,318  in Virtus LifeSci Biotech on January 24, 2024 and sell it today you would earn a total of  245.00  from holding Virtus LifeSci Biotech or generate 10.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

ProShares Decline of  vs.  Virtus LifeSci Biotech

 Performance 
       Timeline  
ProShares Decline 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in ProShares Decline of are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, ProShares Decline is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Virtus LifeSci Biotech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Virtus LifeSci Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental drivers, Virtus LifeSci is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

ProShares Decline and Virtus LifeSci Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ProShares Decline and Virtus LifeSci

The main advantage of trading using opposite ProShares Decline and Virtus LifeSci positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProShares Decline position performs unexpectedly, Virtus LifeSci can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virtus LifeSci will offset losses from the drop in Virtus LifeSci's long position.
The idea behind ProShares Decline of and Virtus LifeSci Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm